Answers are grounded in this paper and cite their sources.
Computational pharmaceutics is the result of a paradigm change brought about by the convergence of artificial intelligence (AI) and massive amounts of data in the field of pharmaceutics. This cutting-edge field uses the unmatched power of AI algorithms or machine learning techniques to analyse, examine, and forecast the complex nuances of pharmaceutical data. In doing so, computational pharmaceutics gives researchers the ability to model medication distribution and formulation procedures, eliminating the need for lengthy repetitions of trial and error. AI algorithms create therapeutic sequences with enhanced stability, affinity for binding, and perfect safety profile by analysing the enormous amounts of data. Target identity, protein folding anticipation, toxicity examination, and clinical experiment optimisation are all part of the AI symphony.
No takes yet. Share an insight, caveat, or question.
Banerjee et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: